Ansell Ltd (ASX: ANN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ansell Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ansell Ltd (ASX: ANN)
Latest News
Share Market News
3 beaten-up ASX All Ordinaries shares that surged higher today
Dividend Investing
2 top ASX dividend shares to think about
Mergers & Acquisitions
5 ASX shares that could be primed for takeovers in 2022: Wilsons
Broker Notes
Top brokers name 3 ASX shares to buy today
Share Market News
ASX 200 (ASX:XJO) midday update: BHP and SEEK impress, Beach sinks
Earnings Results
Ansell (ASX:ANN) share price gains despite profits tumbling 27% in ‘challenging’ half
Share Fallers
These were the worst performing ASX 200 shares last week
Industrials Shares
Down 20% in 2022, is the Ansell (ASX:ANN) share price a bargain buy?
Frequently Asked Questions
-
Ansell’s most recent dividend payment was an interim dividend of 32.88 cents in March 2020, which was unfranked. Thus far, it has not made any announcements regarding further dividend payments in 2020.
-
Yes, Ansell offers a dividend reinvestment plan (DRP) as an alternative to receiving cash dividends on Ansell ordinary shares.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
21 Feb 2022 | $0.3367 | 0.00% | Interim | 09 Mar 2022 |
30 Aug 2021 | $0.5944 | 0.00% | Final | 16 Sep 2021 |
22 Feb 2021 | $0.4190 | 0.00% | Interim | 10 Mar 2021 |
31 Aug 2020 | $0.3811 | 0.00% | Final | 17 Sep 2020 |
24 Feb 2020 | $0.3288 | 0.00% | Interim | 12 Mar 2020 |
16 Aug 2019 | $0.3833 | 0.00% | Final | 05 Sep 2019 |
22 Feb 2019 | $0.5830 | 50.17% | Interim | 14 Mar 2019 |
24 Aug 2018 | $0.3414 | 0.00% | Final | 13 Sep 2018 |
16 Feb 2018 | $0.2588 | 44.13% | Interim | 08 Mar 2018 |
18 Aug 2017 | $0.2998 | 0.00% | Final | 08 Sep 2017 |
17 Feb 2017 | $0.2638 | 0.00% | Interim | 10 Mar 2017 |
19 Aug 2016 | $0.3097 | 0.00% | Final | 08 Sep 2016 |
11 Feb 2016 | $0.2795 | 0.00% | Interim | 10 Mar 2016 |
13 Aug 2015 | $0.3119 | 0.00% | Final | 10 Sep 2015 |
12 Feb 2015 | $0.2567 | 0.00% | Interim | 11 Mar 2015 |
28 Aug 2014 | $0.2357 | 0.00% | 24 Sep 2014 | |
26 Feb 2014 | $0.1828 | 0.00% | Interim | 25 Mar 2014 |
16 Feb 2012 | $0.1500 | 0.00% | Interim | 14 Mar 2012 |
17 Feb 2011 | $0.1400 | 0.00% | Interim | 16 Mar 2011 |
31 Aug 2010 | $0.1750 | 0.00% | Final | 29 Sep 2010 |
11 Mar 2005 | $0.0700 | 57.14% | 08 Apr 2005 |
ANN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Ansell Ltd
Ansell Limited (ASX: ANN) is a global leader in health and safety protection solutions. The company operates in two main business segments, healthcare and industrial, to provide a range of personal protective equipment and safety devices.
Starting out from humble beginnings as a condom manufacturer in the early 1900s, Ansell is now known for primarily manufacturing a range of gloves using different materials for varying uses. With this, the company manufactures more than 10 billion gloves per year and protects more than 10 million people each day. Ansell provides protection solutions to more than 25 industries and has customers in over 100 countries across the globe.
In 1969, Ansell was acquired by Pacific Dunlop, an Australian conglomerate that was once one of the largest companies in the country. However, after selling and spinning off most of its businesses, Pacific Dunlop was renamed Ansell in 2002. Since then, the Ansell share price has gone from strength to strength, delivering capital gains to many shareholders over the years as well as income in the form of dividends.
ANN Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
16 May 2022 | $27.24 | $0.34 | 1.26% | 372,264 | $27.21 | $27.42 | $27.03 |
13 May 2022 | $26.90 | $0.61 | 2.32% | 298,602 | $26.45 | $26.95 | $26.04 |
12 May 2022 | $26.29 | $-0.32 | -1.20% | 345,677 | $26.47 | $26.53 | $26.03 |
11 May 2022 | $26.61 | $0.50 | 1.91% | 400,802 | $26.11 | $26.73 | $25.93 |
10 May 2022 | $26.11 | $-0.32 | -1.21% | 456,764 | $26.32 | $26.35 | $25.66 |
09 May 2022 | $26.43 | $-0.18 | -0.68% | 487,915 | $26.54 | $26.87 | $26.18 |
06 May 2022 | $26.61 | $-0.28 | -1.04% | 330,179 | $26.67 | $26.78 | $26.37 |
05 May 2022 | $26.89 | $-0.48 | -1.75% | 632,623 | $27.44 | $27.44 | $26.76 |
04 May 2022 | $27.37 | $0.12 | 0.44% | 542,682 | $27.50 | $27.93 | $27.29 |
03 May 2022 | $27.25 | $0.17 | 0.63% | 372,608 | $27.11 | $27.46 | $27.02 |
02 May 2022 | $27.08 | $-0.24 | -0.88% | 520,921 | $27.16 | $27.36 | $26.83 |
29 Apr 2022 | $27.32 | $1.10 | 4.20% | 840,185 | $26.34 | $27.34 | $26.30 |
28 Apr 2022 | $26.22 | $0.47 | 1.83% | 375,109 | $25.81 | $26.26 | $25.64 |
27 Apr 2022 | $25.75 | $-0.63 | -2.39% | 680,638 | $26.14 | $26.41 | $25.26 |
26 Apr 2022 | $26.38 | $0.23 | 0.88% | 684,069 | $26.13 | $26.80 | $25.86 |
22 Apr 2022 | $26.15 | $0.06 | 0.23% | 380,902 | $25.89 | $26.34 | $25.75 |
21 Apr 2022 | $26.09 | $-0.05 | -0.19% | 329,359 | $26.20 | $26.45 | $25.83 |
20 Apr 2022 | $26.14 | $0.87 | 3.44% | 616,679 | $25.37 | $26.15 | $25.37 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
29 Apr 2022 | John Bevan | Buy | 124 | $3,380 | Participation in share purchase plan. |
29 Apr 2022 | Christina Stercken | Buy | 181 | $4,934 | Participation in share purchase plan. |
29 Apr 2022 | Christine Yan | Buy | 194 | $5,288 | Participation in share purchase plan. |
31 Mar 2022 | Christine Yan | Buy | 212 | $5,505 | Participation in share purchase plan. |
31 Mar 2022 | Christina Stercken | Buy | 196 | $5,089 | Participation in share purchase plan. |
31 Mar 2022 | John Bevan | Buy | 135 | $3,505 | Participation in share purchase plan. |
15 Mar 2022 | Nigel Garrard | Buy | 500 | $12,250 | On-market trade. |
08 Mar 2022 | Nigel Garrard | Buy | 500 | $12,600 | On-market trade. |
01 Mar 2022 | John Bevan | Buy | 138 | $3,596 | Participation in share purchase plan. |
01 Mar 2022 | Christina Stercken | Buy | 200 | $5,212 | Participation in share purchase plan. |
01 Mar 2022 | Christine Yan | Buy | 215 | $5,602 | Participation in share purchase plan. |
18 Feb 2022 | Christine Yan | Buy | 207 | $5,534 | Participation in share purchase plan. |
18 Feb 2022 | Christina Stercken | Buy | 192 | $5,133 | Participation in share purchase plan. |
18 Feb 2022 | John Bevan | Buy | 132 | $3,529 | Participation in share purchase plan. |
31 Dec 2021 | Christina Stercken | Buy | 160 | $5,254 | Participation in share purchase plan. |
31 Dec 2021 | John Bevan | Buy | 105 | $3,448 | Participation in share purchase plan. |
31 Dec 2021 | Christine Yan | Buy | 173 | $5,681 | Participation in share purchase plan. |
30 Nov 2021 | Christine Yan | Buy | 165 | $5,369 | Participation in share purchase plan. |
30 Nov 2021 | John Bevan | Buy | 101 | $3,286 | Participation in share purchase plan. |
30 Nov 2021 | Christina Stercken | Buy | 153 | $4,978 | Participation in share purchase plan. |
11 Nov 2021 | William Day | Transfer | 8 | $281,092 | Off-market transfer. Assuming 8,972 direct shares transferred to indirect shares |
11 Nov 2021 | William Day | Transfer | 8 | $281,092 | Off-market transfer. Assuming 8,972 direct shares transferred to indirect shares |
29 Oct 2021 | John Bevan | Buy | 105 | $3,349 | Participation in share purchase plan. |
29 Oct 2021 | Christina Stercken | Buy | 160 | $5,104 | Participation in share purchase plan. |
29 Oct 2021 | Christine Yan | Buy | 172 | $5,486 | Participation in share purchase plan. |
30 Sep 2021 | Christine Yan | Buy | 159 | $5,428 | Participation in share purchase plan. |
30 Sep 2021 | Christina Stercken | Buy | 147 | $5,018 | Participation in share purchase plan. |
30 Sep 2021 | John Bevan | Buy | 97 | $3,311 | Participation in share purchase plan. |
31 Aug 2021 | Magnus Nicolin | Exercise | 184 | $6,675,970 | Conversion of securities. 184,621 - performance share rights As per announcement on 02/09/2021 |
31 Aug 2021 | Magnus Nicolin | Buy | 184 | $6,675,970 | Conversion of securities. |
31 Aug 2021 | Magnus Nicolin | Sell | 70 | $2,553,558 | On-market trade. |
31 Aug 2021 | John Bevan | Buy | 92 | $3,303 | Participation in share purchase plan. |
31 Aug 2021 | Christina Stercken | Buy | 152 | $5,458 | Participation in share purchase plan. |
31 Aug 2021 | Christine Yan | Buy | 165 | $5,925 | Participation in share purchase plan. |
27 Aug 2021 | Nigel Garrard | Buy | 1 | $36,375 | On-market trade. |
26 Aug 2021 | John Bevan | Buy | 90 | $3,289 | Participation in share purchase plan. |
26 Aug 2021 | Christina Stercken | Buy | 124 | $4,532 | Participation in share purchase plan. |
26 Aug 2021 | Christine Yan | Buy | 133 | $4,861 | Participation in share purchase plan. |
30 Jun 2021 | Christine Yan | Buy | 104 | $4,567 | Participation in share purchase plan. |
30 Jun 2021 | Christina Stercken | Buy | 70 | $3,074 | Participation in share purchase plan. |
30 Jun 2021 | Leslie Desjardins | Buy | 78 | $3,425 | Participation in share purchase plan. |
30 Jun 2021 | John Bevan | Buy | 144 | $6,324 | Participation in share purchase plan. |
31 May 2021 | John Bevan | Buy | 153 | $6,316 | Participation in share purchase plan. |
31 May 2021 | Leslie Desjardins | Buy | 83 | $3,426 | Participation in share purchase plan. |
31 May 2021 | Christina Stercken | Buy | 73 | $3,013 | Participation in share purchase plan. |
31 May 2021 | Christine Yan | Buy | 110 | $4,541 | Participation in share purchase plan. |
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Nigel David Garrard | Non-Executive Director | Mar 2020 | Mr Garrard is an experienced executive with a track record across FMCG and Industrial/Manufacturing sectors. Mr Garrard has 20 year's experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Mr Garrard was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division and Managing Director of SPC Ardmona. Mr Garrard brings international experience across listed, not-for-profit, government and private entities. He is the Member of the Human Resources Committee (Chair from 1 July 2021) and member of the Sustainability and Risk Committee. He is Chairman of McMahon Services, Non-Executive Director of Hudson Institute of Medical Research and CSR Ltd . Previous Directorships include Managing Director of Orora Limited, Managing Director of Amcor Australasia and Packaging Distribution , Managing Director of SPC Ardmona Limited , Managing Director of Chiquita Brands South Pacific Ltd. |
Mr William G Reilly | Non-Executive Director | Oct 2017 | Mr Reilly has over 35 years experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002. Mr Reilly has served with three Chief Executive Officers and has played pivotal roles leading many of Ansell's corporate strategic and legal initiatives, including M&A, litigation and the successful intellectual property strategy. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. Prior to joining Ansell, Mr Reilly held senior legal positions at C. R. Bard, Inc., The Hertz Corporation and McKesson Corporation. In 2016, Mr Reilly was named on the Financial Times first ever Global GC 30 List. Mr Reilly is Member of the Sustainability and Risk Committee, the Human Resources Committee and the Governance Committee. |
Mr John Andrew Bevan | Non-Executive DirectorNon-Executive Chairman | Aug 2012 | Mr Bevan was formerly the Chief Executive Officer and Executive Director of Alumina Limited and brings to the Board international business experience. Prior to joining Alumina Limited, he had a career with the BOC Group Plc, where he was a member of the Board of Directors and held a variety of senior management positions in Australia, Korea, Thailand, Singapore and the UK. He is Chair of the Governance Committee and member of the Human Resources Committee. He is Chairman of BlueScope Steel Limited, Non-Executive Director of Humpty Dumpty Foundation and Alumina Limited and Former Director of Non-Executive Director of Nuplex Industries Limited, Executive Director of Alumina Limited. |
Ms Leslie A Desjardins | Non-Executive Director | Nov 2015 | Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the US and Australia, including Chief Financial Officer GM Holden, Controller for GM North America, and Finance Director for GM's manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is member of the Sustainability and Risk Committee. She is the Non-Executive Director and Audit and Risk Committee Chair of ALS Limited, Non-Executive Director and Audit Committee Chair of Terry Fox Cancer Foundation and Former Director of Aptar Group. |
Mrs Christina Stercken | Non-Executive Director | Oct 2017 | Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A and operational excellence in growth markets. Before joining EAC, Mrs Stercken served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. Mrs Stercken brings a range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. In her function as Vice Chairman of Myanmar Foundation, Munich, Mrs Stercken supports social Stercken supports social projects in Myanmar. She is the Member of the Sustainability and Risk Committee.She is director of Landis & Gyr Group AG , Myanmar Foundation (Vice Chairman and Former Director of Ascom Holding AG. |
Ms Christine Yingli Yan | Non-Executive Director | Feb 2019 | Ms Yan is an experienced executive who has had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings a range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation and marketing in the businessto- business industry. She is the Member of the Human Resources Committee. She is currently Non-Executive Director of ON Semiconductor Corporation, Non- Executive Director of Modine Manufacturing Company Inc. and Non-Executive Director of Cabot Corporation. |
Mr Neil Salmon | Chief Executive OfficerManaging Director | Sep 2021 | Mr Salmon is currently President of the Industrial Global Business Unit, having served as Chief Financial officer for 6 years. Neil has more than 20 years of experience, gained working across a range of roles in a group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the US and Singapore. After ICI he served as Chief Financial Officer of Innophos in New Jersey, prior to joining Ansell. |
Morten Falkenberg | Non-Executive Director | Nov 2021 | -- |
Ms Catherine Stribley | VP Corporate Governance & Social ResponsibilityCompany Secretary | Apr 2017 | - |
Zubair Javeed | Chief Financial Officer | - | |
Darryl Nazareth | President of the Healthcare GBU (HGBU) | - | |
Catherine Stribley | VP Corporate Governance & Social ResponsibilityCompany Secretary | - |
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 46,082,341 | 36.00% |
J P Morgan Nominees Australia Pty Limited | 19,774,760 | 15.45% |
Citicorp Nominees Pty Limited | 12,892,489 | 10.07% |
National Nominees Limited | 6,829,707 | 5.34% |
HSBC Custody Nominees (Australia) Limited (I) | 2,117,496 | 1.65% |
BNP Paribas Noms Pty Ltd (DRP) | 1,665,259 | 1.30% |
BNP Paribas Nominees Pty Ltd (Agency Lending DRP A/C) | 1,490,115 | 1.16% |
Australian Foundation Investment Company Limited | 1,078,865 | 0.84% |
Netwealth Investments Limited (Wrap Services A/C) | 763,076 | 0.60% |
CPU Share Plans Pty Ltd (PSR Nor Unallocated A/C) | 700,000 | 0.55% |
National Nominees Limited (DB A/C) | 668,908 | 0.52% |
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (DRP A/C) | 611,184 | 0.48% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 409,607 | 0.32% |
BNP Paribas Nominees Pty Ltd Six Sis Ltd (DRP A/C) | 389,719 | 0.30% |
Citicorp Nominees Pty Limited (Colonial First State Inv A/C) | 383,789 | 0.30% |
Australian Executor Trustees Limited (No 1 Account) | 304,745 | 0.24% |
AMP Life Limited | 285,423 | 0.22% |
Mirrabooka Investments Limited | 273,499 | 0.21% |
BNP Paribas Noms (NZ) Ltd (DRP) | 259,347 | 0.20% |
Australian Executor Trustees Limited (IPS Super A/C) | 243,535 | 0.19% |